Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer

Clinical trial NCT00798720 · COMPLETED

Trial details

NCT number: NCT00798720
Sponsor: University of Wisconsin, Madison
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non Small Cell Lung

Start date: 2008-12-01
Primary completion: 2012-10-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.